Renub Research

USA Insulin Pump and CGM Market

Press Release   •   Aug 22, 2017 02:59 EDT

Access Full Research: http://www.renub.com/usa-insulin-pump-market-and-cgm-market-to-cross-usd-5-billion-and-usd-2-billion-in-future-47-nd.php

USA insulin pump market is projected to cross US$ 5 Billion by end of the year 2022. A medical device which is used for the management of insulin in the treatment of diabetes is called “Insulin Pump”. Insulin Pump is a small programme device similar to mobile phone. It is very convenient to use, as this can be easily carried out. The device contains buttons to program insulin and navigates through the menu.

Nowadays in the United States, Insulin Pump has become renowned and a favored device for Type1 diabetes patients. In the United States, rising diabetic patients and increasing alertness towards diabetes, Innovation in technology Drive Insulin pump Market. The use of insulin pump is gaining recognition in the market as insulin delivery systems.

Renub Research, report studies in-depth analysis of Continuous Glucose Monitoring (CGM) Market in the United States.

What is Continuous Glucose Monitoring?

Continuous glucose monitoring (CGM) is a device that allows you to track your glucose continuously all through the day and night, notifying you of ups and downs so you can take action.

The United States Continuous Glucose Monitor (CGM) Market is expected to cross US$ 2 Billion in coming years. Continuous Glucose Monitor (CGM) is very important to all age groups to manage diabetes proficiently. In the United States, the market of CGM has a huge potential in coming years. From the year 2009 to 2016, Continuous Glucose Monitor users have grown to 35 percent.

Many private insurers like (Blue Cross and Blue Shield, Aetna, Cigna etc) have started reimbursing CGM based on certain criteria in the United States (Read the criteria in the report). Many experts in the United States think that CGM is the best tool for diabetes management. For those having several diabetes complications, Continuous Glucose Monitor is very much compatible with that.

In this Report, one can study the product analysis of the United States Insulin Pumps i.e. Animas Vibe, Medtronic 530 G with Enlite, Insulet OmniPod, Tandem t: slim and Roche Accu-Chek Combo.

Report Studies the Reimbursement Policies of USA States - Insulin Pump, Pump Supplies & Diabetes Supplies, CGM

• CALIFORNIA
• DELAWARE
• FLORIDA
• MASSACHUSETTS
• MICHIGAN
• MONTANA
• NEBRASKA
• NEW JERSEY
• NEW YORK
• OKLAHOMA
• RHODE ISLAND
• SOUTH DAKOTA
• TENNESSEE
• TEXAS
• WASHINGTON


Private Insurer Reimbursement Policy for Insulin Pump & CGM

  • Blue Cross and Blue Shield
  • Aetna
  • Cigna
  • United Healthcare
  • Contact Us

    Rajat Gupta

    Sr. Marketing Manager

    Email: info@renub.com

    Phone: +1-678-302-0700

    Web: www.renub.com

    Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

    Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.